AbCellera's second quarter revenue of $4.1M misses estimates as its net loss widens to $55.4M.

AbCellera reported second quarter 2026 revenue of $4.1 million, a significant decrease from $17.1 million in the same period last year. The company posted a net loss of $55.4 million, or ($0.18) per share, compared to a net loss of $34.7 million, or ($0.12) per share, in the prior-year quarter.

Key Highlights

• Revenue of $4.1 million missed analyst expectations of $7.85 million, primarily due to a sharp decline in licensing and royalty revenue compared to the prior year.
• The company's net loss widened to $55.4 million from $34.7 million a year ago, exceeding the consensus estimate for a loss of $48.6 million.
• AbCellera announced new collaborations with Jazz and Vertex, securing over $100 million in combined upfront payments to support its pipeline.
• The company expects to announce top-line data for its Phase 2 ABCL635 trial in August 2026 and ended the quarter with over $675 million in total available liquidity.